Aging Europe And Digital Adoption Will Advance Long Term Care

Published
05 May 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
€5.16
10.1% undervalued intrinsic discount
08 Aug
€4.64
Loading
1Y
133.0%
7D
3.7%

Author's Valuation

€5.2

10.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 Aug 25
Fair value Increased 5.09%

Clariane’s fair value has been revised upward as improving net profit margin outweighed the impact of a higher discount rate, resulting in the consensus price target rising from €4.91 to €5.16. What's in the News Clariane SE expects organic sales growth of around 5% for 2025, supported by strong momentum in France and Germany, with ramp-up contributions in the Netherlands and Spain.

Shared on29 Jul 25
Fair value Increased 8.35%

Clariane’s higher future P/E ratio and improved net profit margin signal increased market confidence in its earnings outlook, supporting the consensus analyst price target increase from €4.53 to €4.91. Valuation Changes Summary of Valuation Changes for Clariane The Consensus Analyst Price Target has risen from €4.53 to €4.91.